Phase
Condition
Female Hormonal Deficiencies/abnormalities
Wolman Disease
Hormone Deficiencies
Treatment
Cosyntropin stimulation test
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria for healthy volunteers:
Male and female outpatients 18 years or older without prior diagnosis of primary or central adrenal insufficiency.
Inclusion Criteria for patients with known adrenal insufficiency:
Males and females 18 years or older with established diagnosis of primary or central adrenal insufficiency as previously documented in the electronic medical record by a failed CST (peak cortisol level < 18 μg/dL) or morning serum cortisol < 3 mcg/dL with an appropriate clinical circumstance (e.g. Sheehan's syndrome, pituitary surgery and/or irradiation, bilateral adrenalectomy, etc) that strongly supports a true diagnosis of primary or central adrenal insufficiency, and current use of physiologic, replacement dose glucocorticoids. Inpatients with non-critical illness and outpatients are eligible.
Inclusion Criteria for patients with suspected adrenal insufficiency:
Males and females 18 years or older with suspected diagnosis of primary or central adrenal insufficiency by any cause based on clinical evaluation by a study team member. Inpatients with non-critical illness and outpatients are eligible.
Exclusion Criteria for all groups:
Moderate to severe liver impairment or abnormal albumin or cortisol binding globulin concentrations
Renal impairment with eGFR < 60 mL/min/1.73m2 and/or diagnosis of nephrotic syndrome
Pregnancy or nursing mothers
Use of estrogen preparations
Major depressive disorder, severe malnutrition, anorexia, chronic fatigue syndrome (disorders that alter HPA axis function)
Use of any medications that induce hepatic cytochrome P-450 enzymes, e.g., barbiturates, phenytoin, rifampin, amino-glutethimide and mitotane
Active medical treatment of Cushing's syndrome (status-post surgical treatment is acceptable)
Uncontrolled hypo- or hyperthyroidism
Use of biotin within the past 72 hours
Regular alcohol and/or cannabis use
Be assessed by the investigators as unsuitable for participation in this study for any reason.
Additional Exclusion Criteria for healthy volunteers only:
Regular use of any oral glucocorticoid (e.g. hydrocortisone, prednisone, dexamethasone) within 6 weeks of the screening visit
Use of oral or nasal steroid (glucocorticoid) inhalers in the past 2 weeks
Regular use of any steroid creams, gels, ointments, or lotions
Use of steroid (glucocorticoid) injections in the past 6 months
Regular use of opioids
Regular use of suboxone
Regular use of megestrol acetate
Study Design
Study Description
Connect with a study center
Montefiore Medical Center
Bronx, New York 10467
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.